Infusional 5-fluorouracil in breast cancer
- 31 October 1994
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 20 (4) , 357-364
- https://doi.org/10.1016/0305-7372(94)90017-5
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Infusional 5 fluorouracil given as a single agent in relapsed breast cancer: Its activity and toxicityThe Breast, 1994
- Preclinical and clinical aspects of biomodulation of 5-fluorouracilCancer Treatment Reviews, 1994
- Continuous Intravenous Infusion of 5-Fluorouracil in the Treatment of Refractory Breast CancerAmerican Journal of Clinical Oncology, 1989
- 5-fluorouracil rechallenge by protracted infusion in refractory breast cancerCancer, 1989
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989
- Low-dose continuous infusion 5-fluorouracil. Evaluation in advanced breast carcinomaCancer, 1989
- Continuous 5-fluorouracil infusion in refractory carcinoma of the breastBreast Cancer Research and Treatment, 1987
- Phase I study of protracted venous infusion of 5-fluorouracilCancer, 1981
- A phase III study comparing the clinical utility of four regimens of 5-Fluorouracil.A preliminary reportCancer, 1977
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957